RT Book, Section
A1 Wyer, Peter
A1 Cook, Deborah J.
A1 Vandvik, Per Olav
A1 Richardson, W. Scott
A1 Elbarbary, Mahmoud
A1 Kunz, Regina
A1 Wilson, Mark C.
A2 Guyatt, Gordon
A2 Rennie, Drummond
A2 Meade, Maureen O.
A2 Cook, Deborah J.
SR Print(0)
ID 1183878585
T1 Teachers' Guides to the Users' Guides
T2 Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3rd ed
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 978-0-07-179071-0
LK jamaevidence.mhmedical.com/content.aspx?aid=1183878585
RD 2024/04/23
AB CLINICAL  SCENARIOScenario  1You  are  an  attending  physician  in  your  hospital's  intensive  care  unit  (ICU)  doing  morning  rounds  on  a  patient  with  septic  shock.  The  resident  notes  that  the  patient  is  still  hypotensive  after  receiving  5  L  of  intravenous  Ringer's  lactate  solution  and  asks  if  starch  solution  should  be  administered.Scenario  2You  are  awaiting  the  noon  conference  in  the  ICU  where  a  patient  admitted  that  week  will  be  discussed  in  detail  with  2  attending  physicians,  a  fellow,  2  senior  residents,  and  2  junior  residents.  The  fellow  is  now  addressing  preventive  interventions  as  part  of  admission  orders,  noting  that  this  patient  did  not  receive  heparin  thromboprophylaxis  when  first  admitted  because  his  admitting  diagnosis  was  ruptured  abdominal  aortic  aneurysm.  Now,  2  days  after  the  patient's  surgery,  the  fellow  is  wondering  which  type  of  heparin  to  prescribe.Scenario  3You  are  the  faculty  adviser  for  journal  club  in  your  surgical  residency  program.  The  resident  assigned  to  lead  this  month's  session  attended  the  patient  admitted  from  the  emergency  department  with  ruptured  aortic  aneurysm  from  scenario  2.  She  proposes  to  review  the  literature  on  the  choice  of  low-molecular-weight  heparin  vs  other  prophylactic  alternatives  for  postoperative  patients.